| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.087 | 0.07 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.079 | 0.08 |